Gabapentin use and a claim for memory loss in Mississippi

Mississippi has one of the highest per-capita gabapentin prescribing rates in the nation, driven by the state's elevated chronic pain prevalence, severe opioid crisis impact, and limited healthcare infrastructure across the Mississippi Delta and rural regions. Many Mississippi counties have no neurologist within 100 miles, meaning gabapentin-induced cognitive decline is unlikely to be identified through routine care. The state's population health indicators — among the worst nationally for obesity, diabetes, and cardiovascular disease — create conditions that drive long-term gabapentin prescribing while simultaneously increasing vulnerability to cognitive side effects through renal impairment and vascular cognitive decline.

For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for Mississippi.